EGFL8 and neoplasm: Two different datasets, comprising 649 and 283 tumor specimens, respectively, demonstrated an over 90% and 70%, respectively, 5-year overall survival probability for patients with high EGFL8 expression, but less than 60% and 40%, respectively, for patients with low EGFL8 expression (Fig. 6h & Supplementary Fig. 11 a,b).